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ABSTRACT Initiation of adenovirus (Ad) DNA replica-
tion occurs on viral DNA containing a 55-kilodalton (kDa) pro-
tein at the 5' terminus of each viral DNA strand and on plas-
mid DNAs containing the origin of Ad replication but lacking
the 55-kDa terminal protein (TP). Initiation of replication pro-
ceeds via the synthesis of a covalent complex between an 80-
kDa precursor to the TP (pTP) and the 5'-terminal deoxynu-
cleotide, dCMP. Formation of the covalent pTP-dCMP initia-
tion complex with Ad DNA as the template requires the viral-
encoded pTP and DNA polymerase and, in the presence of the
Ad DNA binding protein, is dependent upon a 47-kDa host
protein, nuclear factor I. Initiation of replication with recom-
binant plasmid templates requires the aforementioned pro-
teins and an additional host protein, factor pL. Deletion mu-
tants of the Ad DNA replication origin contained within the
6.6-kilobase plasmid pLAl were used to analyze the nucleotide
sequences required for the formation and subsequent elonga-
tion of the pTP-dCMP initiation complex. The existence of two
domains within the first 50 base pairs of the Ad genome, both
of which are required for the efficient use of recombinant
DNA molecules as templates in an in vitro DNA replication
system, was demonstrated. The first domain, consisting of a
10-base-pair "core" sequence located at nucleotide positions
9-18, has been identified tentatively as a binding site for the
pTP [Rjinders, A. W. M., van Bergen, B. G. M., van der
Vfiet, P. C. & Sussenbach, J. S. (1983) Nucleic Acids Res. 11,
8777-8789]. The second domain, consisting of a 32-base-pair
region spanning nucleotides 17-48, was shown to be essential
for the binding of nuclear factor I.
Studies on the in vitro replication of the 36,000-bp adenovi-
rus (Ad) genome [Ad DNA with a 55-kilodalton (kDa) termi-
nal protein (TP) covalently linked to each 5' end (Ad DNA-
TP)] have provided considerable information concerning the
protein requirements and mechanism ofAd DNA replication
(see refs. 1-5 for reviews). Reconstitution of Ad DNA repli-
cation in vitro has been accomplished with five highly puri-
fied proteins (3, 6), three of which are viral-encoded (2, 3).
These viral proteins include the Ad DNA binding protein
(Ad DBP), the 80-kDa precursor (pTP) to the TP found at the
5' ends of each viral DNA strand, and a 140-kDa DNA-de-
pendent DNA polymerase (Ad Pol). The two remaining pro-
teins required in the reconstituted system have been purified
from nuclear extracts of uninfected HeLa cells. Nuclear fac-
tor I, a 47-kDa protein involved in the initiation and early
elongation ofAd DNA synthesis in vitro (7), has been shown
to be a site-specific DNA binding protein (8). DNase I cleav-
age-inhibition experiments have localized the nuclear factor
I DNA binding site to a region between nucleotides 17 and 48
of the AdS genome (8). Nuclear factor II, a type I DNA to-
poisomerase, is required for the elongation of replicating in-
termediates to full-length Ad DNA (6). Initiation of Ad DNA
replication proceeds via the synthesis of a covalent complex
between the 80-kDa pTP and 5' dCMP, the first nucleotide of
the nascent DNA strand (9-11). Elongation of nascent DNA
chains, utilizing the 3' hydroxyl end of the dCMP residue as
a primer terminus, can occur in the reconstituted system. In
the presence of Ad DNA-TP, ATP, Mg2+, the four dNTPs,
the pTP, Ad DBP, and nuclear factor I, the Ad Pol synthe-
sizes DNA chains that are 25-35% the length of Ad DNA (3,
6). Addition of nuclear factor II leads to the synthesis of 36-
kb Ad DNA at a rate that approximates in vivo Ad DNA
synthesis (6).
In vitro replication of plasmid DNA molecules containing
the origin of Ad DNA replication but not the 55-kDa TP also
has been reported (12-14). Replication of one such recombi-
nant plasmid, pLA1, resembles the in vitro replication of Ad
DNA-TP in that (i) specific Ad DNA sequences are required
at the terminus of the linearized plasmid DNA template for
replication to occur (12-14); (ii) replication of pLAl DNA
requires the pTP, Ad Pol, Ad DBP, and nuclear factor I, as
does replication of Ad DNA-TP (14, 15); and (iii) replication
of linearized pLAl DNA is initiated by the formation of a
covalent pTP-dCMP complex (12-15). Initiation of DNA
replication on linearized pLAl differs from that on Ad DNA-
TP in the relative efficiencies with which these DNAs are
used as templates (14) and in the requirement for an addition-
al host protein, factor pL (15), for pTP-dCMP complex for-
mation when pLAl DNA is used as the template.
Construction of plasmid DNAs containing the origin ofAd
DNA replication that support formation of the pTP-dCMP
initiation complex has provided a means to determine the
DNA sequences required for the initiation of Ad DNA repli-
cation. Studies using deletion mutant plasmids containing
various lengths of the terminal region of the Ad genome and
base alterations introduced by site-directed mutagenesis (12,
16) have demonstrated a requirement for the region between
nucleotides 9 and 18 of Ad DNA for the in vitro initiation of
Ad DNA synthesis. Sequence determinations of various se-
rotypes of Ad DNA have revealed that this 10-bp "core" se-
quence is perfectly conserved among the human Ads and is
partially conserved in the DNA of the simian, avian, and mu-
rine Ads (17-27). In this communication, we report that an
additional region that is located directly to the 3' side of the
10-bp core sequence and encompasses the nuclear factor I
DNA binding site is required for the efficient use of plasmid
Abbreviations: bp, base pair(s); Ad, adenovirus; kDa, kilodalton(s);
TP, 55-kDa terminal protein; Ad DNA-TP, Ad DNA with a TP cova-
lently linked to each 5' end; Ad DBP, Ad-encoded DNA binding
protein; pTP, 80-kDa percursor of the TP; Ad Pol, 140-kDa Ad-en-
coded DNA polymerase; pTP-Ad Pol, noncovalent complex be-
tween pTP and 140-kDa Ad Pol; kb, kilobase(s).
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
3069
3070 Biochemistry: Guggenheimer etalP
DNA molecules as templates for the initiation and elongation
of Ad DNA replication.
MATERIALS AND METHODS
Materials. [a-32P]dNTPs and [methyl-3H]dTTP were pur-
chased from Amersham. Nitrocellulose filters (HA, 0.45
,um) were from Millipore.
Nucleic Acids. Plasmid pLAl (13) was isolated as de-
scribed (14). All other plasmid DNAs (see Fig. 1) were con-
structed as described (16) and isolated from E. coli strain
DH1 by the alkaline NaDodSO4 lysis method (28). Plasmid
DNAs were purified by CsCl gradient centrifugation fol-
lowed by sedimentation through 5-20% sucrose gradients
containing 1 M NaCl (29).
Enzymes. The pTP-Ad Pol fraction (30) and Ad DBP (31)
were purified as described. One unit of the pTP-Ad Pol frac-
tion catalyzed the incorporation of 1 nmol of [3H]dTMP into
an acid-insoluble form in 20 min at 30'C (14). Extracts of
uninfected HeLa nuclei (first DEAE-cellulose pass-through
fraction) were prepared as described (7). Nuclear factor I
and factor pL were purified by the methods of Nagata et al.
(7) and Guggenheimer et al. (15), respectively. E. coli DNA
polymerase I "large fragment" was purchased from Boeh-
ringer Mannheim; restriction endonucleases EcoRI and Sal I
were purchased from New England Biolabs. Conditions for
restriction endonuclease digestion of plasmid DNAs were
those recommended by the manufacturer.
End-Labeling of DNA. Recessed ends produced by EcoRI
digestion of plasmid DNAs were labeled at the 3' end by
using [a-32P]dATP, [a-32P]dTTP, and the E. coli DNA poly-
merase I "large fragment" as described (32).
DNA Synthesis. Reaction mixtures (25 or 50 pl) were as
described (14) and were incubated for 60 min at 30'C.
Assay for the Formation of the pTP-dCMP Complex. Reac-
tion mixtures (50 1.l), processing of samples, electrophore-
sis, autoradiography, and quantitation of the pTP-dCMP
complex were as described (14).
Filter Binding Assays. Retention of labeled DNA frag-
ments on nitrocellulose filter by nuclear factor I was assayed
as described (8).
RESULTS
Nuclear Factor I DNA Binding. The site-specific binding of
nuclear factor I to a region of DNA close to the terminus of
Ad DNA has been reported (3, 8). DNase I cleavage-inhibi-
tion experiments have indicated that the nuclear factor I
binding site is located between nucleotides 17 and 48 of the
Ad5 genome (8). To confirm the boundaries of the nuclear
factor I binding domain, filter binding assays were per-
formed with highly purified nuclear factor I and deletion mu-
tant derivatives of plasmid pLA1. pLA1 DNA contains the
left-hand terminal 3.3-kb Bgl II D fragment of AdS DNA.
Plasmid DNAs harboring deletions of the AdS terminal re-
gion were constructed (16) (Fig. 1).
The interaction of nuclear factor I with 3' 32P-labeled
EcoRI-digested plasmid DNAs displayed a marked depen-
dence on the ionic strength of the reaction mixture and filtra-
tion buffer. At low concentrations of NaCl (50 mM), all of
the plasmid DNAs were retained on nitrocellulose filters by
nuclear factor I (Fig. 2A). Differential binding of nuclear fac-
tor I to plasmid DNAs was observed at 100 and 150 mM
NaCl. Only those plasmid DNAs (pLAS108, pLAS107, R8,
and R17) containing an intact nuclear factor I binding site (as
determined by DNase I inhibition) were retained to a signifi-
cant extent by nuclear factor I under these conditions. Plas-
mids pLAS114 and S201 were not retained on the nitrocellu-
lose filters by nuclear factor I at 150 mM NaCl. These two
plasmid DNAs were not retained on nitrocellulose filters
even in the presence of excess nuclear factor I (Fig. 2B).
Double digestion of pLA1 DNA with EcoRI/Sal I gener-
ates two DNA fragments of 3.0 and 3.6 kb. The larger of
these two fragments contains the cloned AdS DNA se-
quences and the nuclear factor I binding site. Similar diges-
tion of deletion mutant derivatives of pLAl DNA yields a
3.0-kb fragment containing only vector DNA sequences and
a smaller fragment (20-72 bp) containing various extents of
the AdS terminal region. The specificity of nuclear factor I
binding to 3' 32P-labeled EcoRI/Sal I-digested plasmid
DNAs was examined (Fig. 3). Analysis by agarose and poly-
acrylamide gel electrophoresis of the bound DNA fragments
eluted from nitrocellulose filters showed that, under condi-
tions of high ionic strength (150 mM NaCl), only those DNA
fragments that contained an intact nuclear factor I binding
domain were bound to nitrocellulose filters by nuclear factor
I. Vector DNA sequences and fragments containing only 4
bp (S201) and 19 bp (pLAS 114) of the nuclear factor I bind-
ing site were not bound by nuclear factor I under these con-
ditions. At low ionic strength (50 mM NaCl), fragments con-
taining the nuclear factor I binding site, as well as vector
DNA sequences, were retained on nitrocellulose filters
in the presence of nuclear factor I. The exception to these
findings, the smaller EcoRI-Sal I fragments of plasmids
pLAS114 (35 bp) and S201 (20 bp) were not adsorbed to ni-
trocellulose under conditions of either high or low ionic
strength.
Template Activity of Deletion Mutants. EcoRI-digested
pLA1 DNA and the deletion derivatives were examined for
their ability to support formation of the pTP-dCMP initiation
complex (Table 1). In reactions containing the purified viral
DNA replication proteins and the purified host factor pL, a
basal level of pTP-dCMP complex was formed in the pres-
ence of DNAs that contained the 5' terminal 20 bp of the Ad
genome (pLA1, pLAS108, pLAS107, pLAS114, and S201).
(bp)
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FIG. 1. End points of deletion mutants. The DNA fragments
containing deleted sequences extending from the 3' end towards the
EcoRI site (pLAS108, pLAS107, pLAS114, and S201) were sub-
cloned into plasmid pAT by the addition of a Sal I linker. DNA
fragments containing deleted sequences beginning at the 5' end (R8
and R17) were subcloned by the addition of an EcoRI linker. Small
letters indicate the EcoRI linker DNA sequences at the 5' end of the
plasmid DNA molecules after digestion with EcoRI. Capital letters
indicate Ad DNA sequences. ------, Sequences present in the various
deletion mutants; , deleted DNA sequences: underlined se-
quences (bp 9-18), the 10-bp core sequence (ref. 33; see Discus-
sion); bold letters, the nuclear factor I binding site as determined by
DNase I cleavage inhibition (8) and nitrocellulose filter binding (this
study). Note that, in deletion mutants R8 and R17, the 5'-terminal
Ad G-C bp is restored by the addition of the EcoRI linker, whereas
Ad bp 49 and 50 in deletion mutant pLAS107 are restored by ligation
of the Sal I linker.
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FIG. 2. Retention of plasmid DNAs on nitrocellulose filters by
nuclear factor I. Filter binding assays were performed as described
(8). (A) Binding of plasmid DNAs by nuclear factor I as a function of
NaCl concentration. Reaction mixtures (50 pl) containing 0.5 fmol
(as molecules) of 3' 32P-labeled EcoRI-digested plasmid DNA
(10,000 cpm/fmol), 5 ng of nuclear factor I (glycerol gradient frac-
tion), and the indicated concentration of NaCl were incubated for 20
min at 0C. The mixtures were filtered, washed five times with 0.4
ml of a mixture containing 25 mM Hepes-NaOH buffer (pH 7.5), 5
mM MgCl2, 4 mM dithiothreitol, and the same concentration of
NaCl as that present in the reaction mixture, and dried, and radioac-
tivity was determined by Cerenkov radiation. (B) Reaction mixtures
(50 jul) containing 0.5 fmol (as molecules) of 3' 32P-labeled EcoRI-
digested plasmid DNA, 150 mM NaCl, and the indicated amount of
nuclear factor I were incubated, filtered, and washed as described
above. Plasmid DNAs and Ad sequences present in these DNAs (in
parentheses) were as follows: o, pLA1 (1-3290); A, pLAS108 (1-72);
*, pLAS107 (1-48); e, pLAS114 (1-35); o, S201 (1-20);m, R8 (7-75);
o, R17 (15-75) DNAs.
Addition of purified nuclear factor I stimulated formation of
the pTP-dCMP initiation complex (5- to 7-fold) with plasmids
that contained a minimum of the terminal 48 bp of Ad DNA.
Plasmids pLAS114 and S201 showed no increase in efficien-
cy as templates for the initiation reaction upon addition of
nuclear factor I. Plasmids R8 and R17 did not support forma-
tion of detectable levels of the pTP-dCMP initiation complex
in either the absence or presence of nuclear factor I.
Extracts of Ad-infected HeLa nuclei (12, 13), or extracts
of uninfected HeLa nuclei supplemented with purified viral
DNA replication proteins (14), catalyze the in vitro initiation
and elongation of nascent DNA chains using linearized
pLA1 DNA as the template. Deletion mutant derivatives of
pLA1 DNA were examined for their ability to support pTP-
primed DNA synthesis (Fig. 4). EcoRI-linearized plasmid
pLA1 and deletion mutant derivatives pLAS108 and
pLAS107 (containing Ad sequences 1-3290, 1-72, and 1-48,
respectively) supported DNA synthesis in reaction mixtures
containing the purified pTP-Ad Pol fraction and Ad DBP,
FIG. 3. Specificity of DNA binding by nuclear factor I. Reaction
mixtures (50 pL) containing 0.5 rmol (as molecules) of 3' 32P-labeled
EcoRI/Sal I-digested plasmid DNA and 50 mM (lanes 2 and 3) or
150 mM (lanes 4 and 5) NaCl in the absence (lanes 2 and 4) or pres-
ence (lanes 3 and 5) of 5 ng of nuclear factor I were incubated, and
the reaction products were filtered and washed as described in the
legend to Fig. 2. After filtration, DNA fragments of doubly digested
pLA1 (A), pLAS108 (B), pLAS107 (C), pLAS114 (D), S201 (E), and
R17 (F) DNAs that were retained on the nitrocellulose filters were
eluted as described (8) and analyzed on 0.8% agarose (A-F Upper)
or 17.5% polyacrylamide gels (B-F Lower) in 89 mM Tris borate
buffer, pH 8.3/2 mM EDTA. Lane 1 (A-F) contained EcoRI/Sal I-
digested plasmid DNA that was applied directly to the nitrocellulose
filter and eluted as above.
supplemented with either crude extracts of uninfected HeLa
nuclei (Fig. 4 Left) or purified nuclear factor I and factor pL
(Fig. 4 Right). EcoRI-linearized plasmid DNAs containing
deletions of the nuclear factor I binding domain (pLAS114
and S201) and recombinant DNAs containing deletions from
Table 1. pTP-dCMP initiation complex formation with plasmid
DNA templates
pTP-dCMP
complex
formed, %
Template DNA A B
pLA1 22 100
pLAS108 11 60
pLAS107 10 72
pLAS114 9 13
S201 7 7
R8 <2 <2
R17 <2 <2
Formation of the pTP-dCMP initiation complex was assayed in
reaction mixtures (50 1l) containing 6.0 fmol (as molecules) of
EcoRI-digested plasmid DNA, the pTP-Ad Pol complex (0.014 unit,
glycerol gradient fraction), a 20-fold excess (wt/wt) of the Ad DBP
to DNA, and factor pL (0.4 ,g) in the absence (column A) or pres-
ence (column B) of nuclear factor I (7.5 ng, glycerol gradient frac-
tion). In this experiment, 100% was equivalent to 0.1 fmol of pTP-
dCMP complex formed in 60 min at 30'C.
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FIG. 4. Template activity of plasmid DNAs. DNA synthesis was
measured in reaction mixtures of 50 A.l (Left) or 25 p.l (Right) con-
taining 0.018 unit of the pTP-Ad Pol complex (glycerol gradient frac-
tion) and (i) a 10-fold excess (wt/wt) of Ad DBP to EcoRI-linearized
plasmid DNA template and 1.5 pAg of uninfected HeLa nuclear ex-
tract (Left) or (ii) a 20-fold excess (wt/wt) of Ad DBP to template,
4.0 ng of nuclear factor I, and 0.2 pug of factor pL (Right). After
incubation for 60 min at 30'C, reactions were terminated and acid-
insoluble radioactivity was determined as described (14). Plasmid
DNAs containing Ad sequences (in parenthesis) were as follows.
(Left) e, pLA1 (1-3290); A, pLAS108 (1-72); o, pLAS107 (1-48); a,
pLAS114 (1-35); A, S201 (1-20); *, R8 (7-75); *, R17 (15-75).
(Right) Symbols were as in Left with the exception that the symbol
* represents the activity obtained with plasmid DNAs S201, R8, and
R17.
the 5' EcoRI site were inactive as templates for DNA synthe-
sis. DNA synthesis with pLA1, pLAS108, and pLAS107
DNAs, using either the crude extract of uninfected HeLa
nuclei or purified host replication factors, commenced after
a 10- to 15-min lag and remained linear for 120 min at 30'C.
DNA synthesis was not observed when EcoRI-digested plas-
mid DNAs pLAS114, S201, R8, and R17 were used as tem-
plates, even after incubation for 120 min at 30TC. Increased
concentrations of the Ad DBP or crude extracts from unin-
fected HeLa nuclei reduced the rate and extent ofDNA syn-
thesis with active templates but did not lead to significant
dNMP incorporation with inactive DNA templates (data not
shown). Therefore, with optimal conditions for the EcoRI-
digested pLAl DNA template and under conditions of limit-
ing DNA concentration, DNA synthesis required the 5'-ter-
minal 18 bp of the Ad genome and additional 3' DNA se-
quences that comprise the nuclear factor I binding domain.
Alkaline agarose gel electrophoresis of products formed
in reactions containing the pTP-Ad Pol fraction, Ad DBP,
factor pL, and nuclear factor I demonstrated that full-
length DNA was synthesized when either pLA1 (6.6 kb) or
pLAS107 (3.0 kb) DNA was used as the template (unpub-
lished results). These results, along with those that demon-
strated that equimolar concentrations of EcoRI-digested
pLA1 and pLAS107 DNAs supported formation of the pTP-
dCMP initiation complex to approximately the same extent
(Table 1), account for the differences in the dNMP incorpo-
ration observed when these DNAs were used as templates
(Fig. 4 Right).
DISCUSSION
Plasmid pLA1 DNA, which contains the 3.3-kb left end of
Ad5 DNA, supports the formation and elongation of the
pTP-dCMP initiation complex, provided that the DNA is lin-
earized in such a way as to place the cloned Ad DNA se-
quences at the terminus of the linear molecule (13, 14, 34). In
vitro mutagenized derivatives of pLA1 DNA have been con-
structed (16) and analyzed for their ability to support in vitro
Ad DNA replication. The results presented in this paper
demonstrate that the terminal 50 bp of the Ad genome are
required for the efficient use of plasmid DNAs as templates
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FIG. 5. Schematic representation of the two DNA domains re-
quired for Ad DNA replication. (A) Domain I can be divided into
two areas: A, a 10-bp core sequence (underlined) that the pTP may
recognize and bind, and B, a spacer region separating the core se-
quence and the terminal dG-dC bp. Arrows represent the boundaries
of the deletion plasmids used to define both domains. (B) Putative
secondary structure of the region at the 5' terminus of EcoRI-digest-
ed pLA1 DNA. Domains I and II overlap at positions 17 and 18.
Boxed areas outline the 10-bp core sequence present in domain I
(solid line) and the nuclear factor I binding site in domain II (broken
line).
for in vitro DNA replication and that these terminal 50 bp are
divided into two functionally distinct domains. The two do-
mains are defined by the existence of three classes of plas-
mid DNAs examined in this study. Class I DNAs are those
to which nuclear factor I binds and act as efficient templates
for the initiation and elongation reactions (pLAl, pLAS108,
and pLAS107); class II DNAs are those to which nuclear
factor I does not bind and are poor templates for formation
of the pTP-dCMP initiation complex and do not support
elongation of the initiation complex (pLAS114, and S201);
class III DNAs are those to which nuclear factor I does bind
but are inactive for initiation and elongation (R8 and R17).
The maximal limits of domain I (Figs. 1 and 5A) are de-
fined by plasmid S201, which contains the terminal 20 bp of
the Ad genome. The 5'-terminal dG-dC bp and a 10-bp core
sequence (bp 9-18) within domain I are perfectly conserved
in the DNA of all human Ads. Plasmid DNAs containing de-
letions from the 5' terminus (R8 and R17), deletions from the
3' end extending into domain I (refs. 16 and 34; unpublished
observations), and single-base substitutions within the core
sequence are almost completely inactive as templates for the
formation of the pTP-dCMP initiation complex. Rijinders et
al. (33) have presented evidence suggesting that the 10-bp
core sequence may provide a binding site for the pTP, thus
explaining the absolute requirement for these DNA se-
quences. The function of the nucleotides between the termi-
nal dG-dC bp and the core sequence is less clear, although it
has been proposed that these nucleotides serve as a spacer
region, which positions the pTP-Ad Pol complex an appro-
priate distance (4-8 bp) from the terminus (12). Challberg
and Rawlins (34) have found that a plasmid containing a
dG-dC to dA-dT transition at position 4 supported the initia-
tion reaction. These results suggest that the exact sequence
of the nonconserved terminal nucleotides is not important.
Our finding that plasmid R8, which contains a dG-dC bp (do-
A
---a
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nated by the EcoRI linker) four bases from the core se-
quence, is completely inactive as a template for the forma-
tion of the pTP-dCMP initiation complex suggests that the
required distance between the 5'-terminal dG-dC bp (at
which Ad DNA replication is initiated) and the 10-bp core
sequence must be greater than four nucleotides.
Domain II, the maximal limits of which are defined from
the 5' end by plasmid R17 to the 3' end by plasmid pLAS107,
is required for nuclear factor I binding and efficient use of
the plasmid DNAs as templates for initiation and chain elon-
gation. These results confirm the limits of the nuclear factor
I binding site as determined by DNase inhibition patterns (8)
and the requirement for nuclear factor I in the replication of
Ad DNA-TP and plasmid DNAs containing the origin of Ad
DNA replication but lacking the 55-kDa TP (15). It is unclear
at present whether nuclear factor I acts both in the initiation
and elongation reactions or solely in the initiation reaction.
DNA synthesis observed with templates containing domain
II may simply be due to the marked increase in the initiation
reaction in the presence of nuclear factor I.
The terminal 50-bp of the Ad genome has the potential to
form a hairpin structure (Fig. 5B) possessing a A G of -6.1
kcal/mol (1 cal = 4.19 J) (8). A region of overlap exists be-
tween domains I and II at the base of the hairpin structure.
Plasmid DNAs containing a dC-*dT transition at either posi-
tion 17 or 18 are still bound by nuclear factor I but are com-
pletely inactive as templates for the formation of the pTP-
dCMP initiation complex (ref. 34; D. Rawlins, personal com-
munication). This region of overlap, at the 3' end of the 10-
bp core sequence, and the 5' end of the nuclear factor I
binding site may constitute a site of direct protein-protein
interaction between the pTP-Ad Pol complex and nuclear
factor I.
It has been reported that plasmid DNAs containing the ter-
minal 20 bp of Ad DNA (i.e., deleted within domain II) sup-
ported formation of the pTP-dCMP initiation complex and
pLA1 DNA replication (16, 34). The apparent discrepancy
between these results and the results presented in this study
may be accounted for by the use of high template concentra-
tions (4,tg/ml) and a limiting amount of nuclear factor I in
previous experiments. Experiments performed with the opti-
mal concentration of crude nuclear extracts of Ad-infected
HeLa cells, prepared by the method of Tamanoi and Still-
man (13), and with low DNA concentrations (0.4 g.g/ml)
confirmed the findings presented in this paper (unpublished
results). The addition of purified nuclear factor I to nuclear
extracts of Ad-infected or uninfected HeLa cells enhanced
the initiation reaction on plasmids containing domain II but
had no effect on plasmid DNAs deleted in this region. These
results suggest that nuclear factor I is i limiting component
in crude extracts and that, in order to observe a nuclear fac-
tor I (or domain II) dependence, low concentrations of tem-
plate DNA must be used when extracts are employed as a
source of replication proteins.
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